CAMEO: Lessons Learned about Cangrelor

Episode 3: A Conversation About Cangrelor and Treating Patients with Cardiogenic Shock

In the third episode of the CAMEO podcast, principal investigator Jennifer Rymer and Babar Basir discuss cangrelor and strategies for treating patients with cardiogenic shock. Tune in to hear their discussion of the pharmacologic considerations for patients with cardiogenic shock and to learn about the National Cardiogenic Shock Initiative at Henry Ford Hospital. You can earn 0.25 CME credits for listening to this episode through the Duke OneLink Continuing Education website. Visit ja.dh.duke.edu/ to create or login to your account and search for CAMEO in the “find a course” field. Follow the steps at duke.is/vy8w8 to register for a Duke One Link account today. Jennifer Rymer, MD, MBA, is the John Bush Simpson Assistant Professor of Medicine at Duke University and Principal Investigator of the CAMEO registry. Dr. Rymer is an interventional cardiologist, and she is a faculty member at the Duke Clinical Research Institute. Dr. Rymer’s disclosures include advisory board and research funding from Chiesi, research funding from Idorsia, and research funding from Pfizer Pharmaceuticals. Babar Basir, DO, is the Director of Acute Mechanical and Circulatory Support at Henry Ford Hospital in Detroit. Dr. Basir’s disclosures include Abiomed, Boston Scientific, Chiesi, Saranas and Zoll. Visit https://duke.is/b/j9ya to view a transcript of this episode.

Episode 2: Cangrelor – Upstream P2Y12 Inhibitor Use

In the second episode of the CAMEO podcast, principal investigator Jennifer Rymer and Dominick Angiolillo discuss their recent research examining cangrelor use in the setting of upstream P2Y12 inhibitor use. You can earn 0.25 CME credits for listening to this episode through the Duke One Link Continuing Education website. Visit ja.dh.duke.edu/ to create or login to your account and search for CAMEO in the “find a course” field. Follow the steps at duke.is/vy8w8 to register for a Duke OneLink account today. Jennifer Rymer, MD, MBA, is the John Bush Simpson Assistant Professor of Medicine at Duke University and Principal Investigator of the CAMEO registry. Dr. Rymer is an interventional cardiologist, and she is a faculty member at the Duke Clinical Research Institute. Dr. Rymer’s disclosures include advisory board and research funding from Chiesi, research funding from Idorsia, and research funding from Pfizer Pharmaceuticals. Dominick Angiolillo, MD, PhD, FACC, is Professor and Chief of the Division of Cardiology, Medical Director of the University of Florida Health Cardiovascular Center in Jacksonville, Medical Director of the Cardiovascular Research Program, and Program Director of the Interventional Cardiology Fellowship. Dr. Angiolillo’s disclosures include consulting fees or honoraria from Abbott, Amgen, AstraZeneca, Bayer, Biosensors, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, Daiichi-Sankyo, Eli Lilly, Haemonetics, Janssen, Merck, Novartis, PhaseBio, PLx Pharma, Pfizer, Sanofi and Ventura, outside the present work; he has received research grants from Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, Daiichi-Sankyo, Eisai, Eli Lilly, Gilead, Janssen, Matsutani Chemical Industry Co., Merck, Novartis, Osprey Medical, Renal Guard Solutions and Scott R. MacKenzie Foundation. Visit https://duke.is/6/rfys to view a transcript of this episode.

Episode 1: Observations About P2Y12 Inhibitor Transitions in Cangrelor Treated Patients

In the first episode of the CAMEO podcast, principal investigator Jennifer Rymer and co-investigator Jeff Washam discuss their firsthand experiences with the drug cangrelor and introduce the CAMEO Registry. Tune in to learn more about their recent analysis of CAMEO data, which revealed major variations in clinical use of the drug. You can earn 0.5 CME credits for listening to this episode through the Duke One Link Continuing Education website. Visit https://ja.dh.duke.edu/ to create or login to your account and search for CAMEO in the “find a course” field. Follow the steps at https://duke.is/vy8w8 to register for a Duke OneLink account today. Jennifer Rymer, MD, MBA, is the John Bush Simpson Assistant Professor of Medicine at Duke University and Principal Investigator of the CAMEO registry. Dr. Rymer is an interventional cardiologist, and she is a faculty member at the Duke Clinical Research Institute. Jeffrey Washam, PharmD, FAHA, is a clinical pharmacist in the Cardiac Intensive Care Unit at Duke University Hospital, co-investigator of the CAMEO registry, and a consulting associate in the Duke Department of Medicine. Visit https://duke.is/rwd3w to view a transcript of this episode.